Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.32 is 32% below its 5-year average of 12.30, near the low end of its 5-year range (7.25–21.10).
As of the fiscal period ended Tuesday, June 30, 2026. 12.55% below its 12-month average of 9.51.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.32.
CURRENT RATIO
8.32
CURRENT RATIO AVG TTM
9.51
CURRENT RATIO AVG 3Y
9.46
CURRENT RATIO AVG 5Y
12.30
CURRENT RATIO AVG 10Y
24.81
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.55%
CURRENT VS 3Y AVG
-12.08%
CURRENT VS 5Y AVG
-32.38%
CURRENT VS 10Y AVG
-66.47%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 800 covered companies
CURRENT VS SECTOR MEDIAN
+131.37%
vs the sector median at left
Market Cap
$10.03B
Current Ratio
3.14
TTM Avg
6.05
3Y Avg
5.87
5Y Avg
4.96
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | $9.61B | 8.32 | 9.51 | 9.46 | 12.30 |
| Henry Schein, Inc. (HSIC)vs › | $9.65B | 1.32 | 1.40 | 1.56 | 1.60 |
| Vaxcyte, Inc. (PCVX)vs › | $9.45B | 5.72 | 10.33 | 12.86 | 11.45 |
| Insulet Corp. (PODD)vs › | $9.38B | 2.48 | 3.16 | 3.34 | 4.18 |
| Bruker Corporation (BRKR)vs › | $9.39B | 1.85 | 1.67 | 1.86 | 2.08 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.03B | 3.14 | 6.05 | 5.87 | 4.96 |
| Molina Healthcare, Inc. (MOH)vs › | $10.01B | 1.68 | 1.66 | 1.58 | 1.56 |
| Repligen Corporation (RGEN)vs › | $10.08B | 9.05 | 8.39 | 6.50 | 5.22 |
| The Ensign Group, Inc. (ENSG)vs › | $10.16B | 1.21 | 1.49 | 1.44 | 1.33 |
| Align Technology, Inc. (ALGN)vs › | $10.19B | 1.40 | 1.29 | 1.26 | 1.29 |
Current Ratio
8.32
Quick Ratio
7.96
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.32 |
| 2026-03-31 | 9.46 |
| 2025-12-31 | 9.95 |
| 2025-09-30 | 10.14 |
| 2025-06-30 | 9.68 |
| 2025-03-31 | 9.65 |
| 2024-12-31 | 7.28 |
| 2024-09-30 | 7.97 |
| 2024-06-30 | 9.50 |
| 2024-03-31 | 12.66 |
| 2023-12-31 | 17.76 |
| 2023-09-30 | 21.10 |
| 2023-06-30 | 20.25 |
| 2023-03-31 | 10.13 |
| 2022-12-31 | 13.30 |
| 2022-09-30 | 14.18 |
| 2022-06-30 | 12.45 |
| 2022-03-31 | 7.25 |
| 2021-12-31 | 17.18 |
| 2021-09-30 | 9.67 |
| 2021-06-30 | 20.42 |
| 2021-03-31 | 44.38 |
| 2020-12-31 | 17.80 |
| 2020-09-30 | 39.96 |
| 2020-06-30 | 51.20 |
| 2020-03-31 | 46.38 |
| 2019-12-31 | 58.88 |
| 2019-09-30 | 54.87 |
| 2019-06-30 | 49.80 |
| 2019-03-31 | 33.28 |
| 2018-12-31 | 43.39 |
| 2018-09-30 | 27.57 |
| 2018-06-30 | 60.22 |
| 2018-03-31 | 105.46 |
| 2017-12-31 | 77.99 |
| 2017-09-30 | 21.26 |
| 2017-06-30 | 6.73 |
| 2017-03-31 | 25.08 |
| 2016-12-31 | 50.44 |
| 2016-09-30 | 0.00 |
